Navigation Links
Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
Date:5/21/2008

paradigms, and enhanced analysis of samples.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and higher) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

Forward Looking Statements

Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include the reported effectiveness of PCT to extract new proteins; the speed of sample preparation using PCT compared with current sample preparation methods; the importance of ProteoSolve-LRS and PCT in the reported identification of new proteins; the speed, cost, and quality advantages of ProteoSolve-LRS and PCT over other sample preparation methods; and the possibility that extraction of proteins by ProteoSolve-LRS and PCT may result in new therapeutic strategies, diagnostic paradigms, and enhanced analysis of samples. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to: unforeseen technological difficulties that the Company may encounter in the development of the PCT technology and the PCT Sample Prepa
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Seven-Year Neck Pain Study Sheds Light on Best Care
2. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
3. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
4. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
5. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
6. Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
7. Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
8. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
11. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) ... secured $1 million in 12% per annum short term ... is an initial drawdown of $500,000, with accrued interest ... of $500,000 with accrued interest and principal repayable in ... Company becoming cashflow positive for any calendar month prior ...
(Date:12/16/2009)... EuroPharma, Inc. signs exclusive multi-year ... of super absorbency BCM-95® curcumin and specialized ... The exclusive distribution territory for these clinically-studied ... channel and professional channel, which includes allopathic ... BCM-95® is a highly absorbable curcumin. ...
(Date:12/16/2009)... 16 RealMed has been ranked ... the 2009 Top 20 Best in ... report. RealMed is a dynamic revenue cycle ... processing between healthcare providers and all ... firm specializing in vendor performance measurement in ...
Breaking Medicine Technology:HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3New impact factor of European Urology underlines journals outstanding position 50912 1New impact factor of European Urology underlines journals outstanding position 50912 2Food crisis and global health workshop July 14 16 50910 1Coralline algae in the Mediterranean lost their tropical element between 5 and 7 million years ago 9137 1Coralline algae in the Mediterranean lost their tropical element between 5 and 7 million years ago 9137 2
(Date:12/16/2009)... Dec. 16 For wounded U.S. ... Center in Washington, D.C., the holidays can be a ... to travel home rely more than ever on the ... This week, calling home just got easier for Walter ... calling cards, which will provide hundreds of minutes of ...
(Date:12/16/2009)... Scientists pinpoint seven that increase susceptibility to disease ... genes associated with increased susceptibility to leprosy have ... , The researchers, who analyzed more than 10,000 ... in China, said their discovery highlights the important ... the development of leprosy. , "Though leprosy is ...
(Date:12/16/2009)... fatty acids commonly found in fatty fish and ... research published by the American Psychological Association. The ... found in people with schizophrenia; bipolar, obsessive-compulsive, and ... of the nervous system. , The study, ... provides more evidence that fish is brain food. ...
(Date:12/16/2009)... technology and the provider of the optimal paper-based e-data capture ... among the Fastest Growing Technology Companies on the Deloitte Technology ... ... (PRWEB) December 16, 2009 -- Kayentis provides ... of handwritten data. Kayentis targets the Healthcare and Life Sciences ...
(Date:12/16/2009)... all-time low, government report shows, , , WEDNESDAY, Dec. 16 ... States has reached almost 78 years, a record high, ... 2007, women can expect to live to 80.4 years ... the report from the U.S. Centers for Disease Control ... expect to live longer than their parents, life expectancy ...
Breaking Medicine News(10 mins):Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:Leprosy Genes Identified 2Health News:New study links DHA type of omega-3 to better nervous-system function 2Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2Health News: Life Expectancy in U.S. Hits New High 2Health News: Life Expectancy in U.S. Hits New High 3
... attacks and related cardiovascular problems occurring in people who ... long sought medications to increase the amount of this ... a new review of 31 randomized controlled trials published ... that so far, only modest evidence supports the use ...
... University Medical Center researchers have demonstrated using functional ... increased in stroke and traumatic brain injury survivors ... treatment that helps these patients recover lost vision. ... peer-reviewed journal Neurorehabilitation and Neural Repair on Aug. ...
... their physician will you be delivering my baby" Dr. ... determine whether obstetric outcomes differed between women whose babies ... by an on-call obstetrician who did not provide antenatal ... single term births between 1991 and 2001 at the ...
... indicates that the loss of two types of brain ... of symptoms associated with Parkinson,s disease. , The evidence, ... loss of both norepinephrine and dopamine neurons and the ... was originally thought that the loss of only dopamine ...
... safe and may produce beneficial changes in the brains ... to an article posted online today that will appear ... Neurology, one of the JAMA/Archives journals. , In patients ... myelin sheaths that protect nerve cells in the brain ...
... spawns an enzyme that inactivates two tumor-suppressing genes, ultimately ... cancer cells, researchers at The University of Texas M. ... of the journal Cell. , "This is a completely ... targets for clinical intervention," senior author Mien-Chie Hung, Ph.D., ...
Other Medicine News:Health News:New review suggests caution on drugs to raise 'good' cholesterol 2Health News:New review suggests caution on drugs to raise 'good' cholesterol 3Health News:Vision restoration therapy shown to improve brain activity in brain injured patients 2Health News:Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinson's symptoms 2Health News:DNA vaccine against multiple sclerosis appears safe, potentially beneficial 2Health News:Pathway links inflammation, angiogenesis and breast cancer 2Health News:Pathway links inflammation, angiogenesis and breast cancer 3
... knee prosthesis stems from many years of ... manufacturing technologies have been used in order ... as a favorable pressure distribution pattern on ... to a minimum. The inherent design of ...
... Knee design includes several innovative ... porous coating option for stable ... unique bone preserving posterior stabilizing ... to maximize range of motion, ...
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i...
Scorpio CR Knee is designed to address normal knee kinematics, range of motion (ROM) and polyethylene wear....
Medicine Products: